| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/10/2007 | CA2617723A1 Novel cxc-chemokine antagonists |
| 05/10/2007 | CA2612479A1 Production of bone morphogenic proteins (bmps) in transgenic mammals |
| 05/09/2007 | EP1783491A1 Method of screening vascular smooth muscle cell growth inhibitor and growth promoter |
| 05/09/2007 | EP1783227A1 Humanized anti-CCR2 antibodies and methods of use therefor |
| 05/09/2007 | EP1783226A1 AAV structural protein, production and use thereof |
| 05/09/2007 | EP1783225A1 AAV structural protein, production and use thereof |
| 05/09/2007 | EP1783222A1 Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity. |
| 05/09/2007 | EP1783215A1 Angiostatin and method of use for inhibition of angiogenesis |
| 05/09/2007 | EP1783140A2 Neovascular-specific peptides |
| 05/09/2007 | EP1783139A2 Human telomerase catalytic subunit |
| 05/09/2007 | EP1782849A2 Three-dimensional stromal tissue |
| 05/09/2007 | EP1782838A1 Inhibition of infiltration, and cell killing agent |
| 05/09/2007 | EP1782829A1 Preventive and/or remedy for hyperkalemia containing ep4 agonist |
| 05/09/2007 | EP1782825A2 Treatment of glycogen storage diseases type II |
| 05/09/2007 | EP1782824A2 Diaminooxidase-containing pharmaceutical preparations |
| 05/09/2007 | EP1782823A2 IL-21 peptides and nucleic acids |
| 05/09/2007 | EP1782822A1 Remedy for melaonoma |
| 05/09/2007 | EP1782821A1 Drug and method for improving brain function |
| 05/09/2007 | EP1782820A1 Method of screening toxin-neutralizing peptide, stx2 inhibitory peptide and vero toxin-neutralizing agent |
| 05/09/2007 | EP1782819A1 Oligopeptides and their use |
| 05/09/2007 | EP1782806A1 Compositions for treating dermatological and neurological disorders |
| 05/09/2007 | EP1782800A2 JAK/STAT pathway inhibitors and the uses thereof |
| 05/09/2007 | EP1782072A2 Materials and methods for screening modulators of neural regneration |
| 05/09/2007 | EP1781788A2 Chicken deoxycytidine and deoxyadenosine kinase enzymes and their use |
| 05/09/2007 | EP1781782A1 Modified vitamin k dependent polypeptides |
| 05/09/2007 | EP1781780A2 Treating cancer |
| 05/09/2007 | EP1781700A1 Rage fusion proteins and methods of use |
| 05/09/2007 | EP1781697A2 Novel carbamylated epo and method for its production |
| 05/09/2007 | EP1781695A1 Selective vpac2 receptor peptide agonists |
| 05/09/2007 | EP1781694A1 Selective vpac2 receptor peptide agonists |
| 05/09/2007 | EP1781693A2 Selective vpac2 receptor peptide agonists |
| 05/09/2007 | EP1781692A2 Selective vpac2 receptor peptide agonists |
| 05/09/2007 | EP1781689A1 Conjugates and therapeutic uses thereof |
| 05/09/2007 | EP1781688A1 Compounds for proteasome enzyme inhibition |
| 05/09/2007 | EP1781687A1 Alpha-keto carbonyl calpain inhibitors |
| 05/09/2007 | EP1781686A2 Vla-4 antagonists |
| 05/09/2007 | EP1781685A1 Therapeutic and diagnostic agents |
| 05/09/2007 | EP1781684A2 A novel chimeric polypeptide and use thereof |
| 05/09/2007 | EP1781682A1 B7-h5, a costimulatory polypeptide |
| 05/09/2007 | EP1781596A1 Amino acid derived prodrugs of propofol compositions and uses thereof |
| 05/09/2007 | EP1781377A2 Elastase inhibitor in leukemia |
| 05/09/2007 | EP1781324A2 Pharmaceutically active insulin receptor-modulating molecules |
| 05/09/2007 | EP1781323A1 Composition comprising a pulmonary surfactant and a tnf-derived peptide |
| 05/09/2007 | EP1781322A1 Method for treating diabetes |
| 05/09/2007 | EP1781321A1 A method of treating cancer comprising a vegf-b antagonist |
| 05/09/2007 | EP1781320A2 Use of thyrotropin for regeneration of bone |
| 05/09/2007 | EP1781319A2 Method for enhancing bone formation |
| 05/09/2007 | EP1781317A1 Treatment of transformed or infected biological cells |
| 05/09/2007 | EP1781316A2 Cyclic peptides for treatment of cachexia |
| 05/09/2007 | EP1781315A2 Peptide inhibitors for mediating stress responses |
| 05/09/2007 | EP1781314A2 Compounds that inhibit hsp90 protein-protein interactions with iap proteins |
| 05/09/2007 | EP1781313A2 Mycobacterium tuberculosis epitopes and methods of use thereof |
| 05/09/2007 | EP1781312A2 Formulations and methods for modulating satiety |
| 05/09/2007 | EP1781311A2 Growth-hormone secretagogues |
| 05/09/2007 | EP1781310A2 Articles of peptide nanostructures and method of forming the same |
| 05/09/2007 | EP1781303A1 Methods and reagents for the treatment of metabolic disorders |
| 05/09/2007 | EP1781284A1 Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma |
| 05/09/2007 | EP1781267A2 Methods and reagents for the treatment of immunoinflammatory disorders |
| 05/09/2007 | EP1781266A2 Microprojection array patch for transdermal delivery of vascular endothelial growth factors |
| 05/09/2007 | EP1781264A2 Methods for manufacturing delivery devices and devices thereof |
| 05/09/2007 | EP1781182A2 Pleural effusion treatment device, method and material |
| 05/09/2007 | EP1601769B1 Papillosin antimicrobial peptide, a gene for coding said peptide, a vector, a transformed organism and a compound containing said organism |
| 05/09/2007 | EP1601768B1 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide |
| 05/09/2007 | EP1551369A4 Combination therapy for treatment of fibrotic disorders |
| 05/09/2007 | EP1365788B1 Thrombomodulin analogs for use in recovery of spinal cord injury |
| 05/09/2007 | EP1338651B9 Method of screening remedy for diabetes |
| 05/09/2007 | EP1313882B1 Diagnosis and treatment of prostate cancer |
| 05/09/2007 | EP1180143B1 In vitro methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues, pharmaceutical compositions related thereto |
| 05/09/2007 | EP1169058B1 Insulin-like growth factor binding protein-4 protease |
| 05/09/2007 | EP1137792B1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 05/09/2007 | EP1073447B1 N1-modified glycopeptides |
| 05/09/2007 | EP1000149B1 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
| 05/09/2007 | EP0969720B1 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 05/09/2007 | EP0853450B1 Compositions for the treatment of vascular injury |
| 05/09/2007 | EP0793675B9 Hiv-1- and hiv-2-peptides for inhibition of membrane fusion-associated events, including hiv transmission |
| 05/09/2007 | EP0708660B1 Compounds useful for preparing prodrugs of protein tyrosine kinase inhibitors |
| 05/09/2007 | EP0692029B1 Genetically engineered glutaminase and its use in therapy |
| 05/09/2007 | EP0673653B1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it |
| 05/09/2007 | CN1961073A Truncated DANCE, DANCE complex and method of using these |
| 05/09/2007 | CN1961071A Methods and constructs for expressing polypeptide polymers in eukaryotic cells using alternative splicing |
| 05/09/2007 | CN1961001A Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins |
| 05/09/2007 | CN1960825A Functionalized colloidal metal compositions and methods |
| 05/09/2007 | CN1960766A Novel G-CSF conjugates |
| 05/09/2007 | CN1960758A Remedy or preventive for arthritis |
| 05/09/2007 | CN1960757A Composition for increasing body height |
| 05/09/2007 | CN1960748A Liquefaction processes |
| 05/09/2007 | CN1960747A Lactalbumin for inhibiting angiogenesis |
| 05/09/2007 | CN1960746A A biomolecule-containing formulation of increased stability |
| 05/09/2007 | CN1960745A Combination dosing regimen for erythropoietin |
| 05/09/2007 | CN1960744A Peptides of il1 beta and tnf alpha and method of treatment using same |
| 05/09/2007 | CN1960737A Treatment with oxaliplatin and EGFR-inhibitor |
| 05/09/2007 | CN1960726A Composition comprising a jnk inhibitor and cyclosporin |
| 05/09/2007 | CN1960720A Novel use of peptide compounds for treating amyotrophic lateral sclerosis |
| 05/09/2007 | CN1960710A Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight |
| 05/09/2007 | CN1960706A Superloaded liposomes for drug delivery |
| 05/09/2007 | CN1959414A Method for filtering out substance of restraining gene orf10 interrelated to nosogenesis of SARS |
| 05/09/2007 | CN1958794A Method for preparing mutant code cDNA of apoptosis induction ligand related to human tumor necrosis factor, and application |
| 05/09/2007 | CN1958793A Method for preparing composite growth factor of natural cells |
| 05/09/2007 | CN1958790A New thrombin in snake poison categories of hundred-paced pit viper, and styptic activity |
| 05/09/2007 | CN1958610A Medication of guiding antibody for anti leukaemia in monocarpotic cellularity |